cohort study, the 2-year discontinuation rate for GLP-1 receptor agonists was 64.1% among people with type 2 diabetes mellitus, driven by factors such as older age, low income, gastrointestinal adverse events, and insufficient weight loss [115]
The escaping microorganism ultimately reaches the liver through the bloodstream (Rocho et al., 2024)
Patients who want or need blood work can access Step One Labs panels starting at approximately $95
Because insurance companies view diabetes as an illness, they often cover GLP-agonists to treat it
The risk of hypoglycaemia with GLP-1 medications is generally low unless they are used in combination with insulin or sulfonylureas
The median (IQR) number of patients across studies was 355 (1295)